Transaction #18018 · Form 4 · 0001493152-25-027107

Immix Biopharma, Inc. · Purchase · Common Stock

Immix Biopharma, Inc. · Transacted December 10, 2025 · Filed December 10, 2025

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for Immix Biopharma, Inc. records a purchase involving Common Stock on December 10, 2025. The reported quantity was 770. The filing date is December 10, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001873835
Security type
Non-derivative
Acquisition type
Purchase · Code P
Quantity acquired
770
Reported price
6.58
Reference value
5,066.6
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
291,429
Ownership description
Not reported
SEC acceptance time
Dec 10, 2025, 6:47 PM EST
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

IMMX · Nasdaq · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.
F2
Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.
F3
The warrants were held by Alwaysraise LLC.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.